HDL protects against doxorubicin-induced cardiotoxicity in a scavenger receptor class B type 1-, PI3K-, and Akt-dependent manner

Kristina K. Durham(Thrombosis and Atherosclerosis Research Institute), Bernardo L. Trigatti(Thrombosis and Atherosclerosis Research Institute)
American Journal of Physiology-Heart and Circulatory Physiology
October 7, 2017
Cited by 23


Related Papers